In this study, we observed that PRDX3 contributed to the invasive ability in two breast cancer cell lines, via upregulation of MMP-1, which is due to the activation of ERK/AP1 signaling, as demonstrated by multi-pathway reporter array and western blotting. Here, JUN is linked to breast carcinoma.